BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28609681)

  • 1. Epigenetic modulation in cancer immunotherapy.
    Gallagher SJ; Shklovskaya E; Hersey P
    Curr Opin Pharmacol; 2017 Aug; 35():48-56. PubMed ID: 28609681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.
    Park J; Thomas S; Munster PN
    Epigenomics; 2015; 7(4):641-52. PubMed ID: 26111034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
    Ali MA; Matboli M; Tarek M; Reda M; Kamal KM; Nouh M; Ashry AM; El-Bab AF; Mesalam HA; Shafei AE; Abdel-Rahman O
    Immunotherapy; 2017 Jan; 9(1):99-108. PubMed ID: 28000527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
    Saleh R; Toor SM; Sasidharan Nair V; Elkord E
    Front Immunol; 2020; 11():1469. PubMed ID: 32760400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy.
    Mazzone R; Zwergel C; Mai A; Valente S
    Clin Epigenetics; 2017; 9():59. PubMed ID: 28572863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Therapeutics: A New Weapon in the War Against Cancer.
    Ahuja N; Sharma AR; Baylin SB
    Annu Rev Med; 2016; 67():73-89. PubMed ID: 26768237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic targeting in pancreatic cancer.
    van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
    Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of novel epigenetic molecular-targeting agents].
    Sowa Y; Sakai T
    Nihon Rinsho; 2015 Aug; 73(8):1263-7. PubMed ID: 26281676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors.
    Terranova-Barberio M; Thomas S; Munster PN
    Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC inhibitors as epigenetic regulators for cancer immunotherapy.
    Conte M; De Palma R; Altucci L
    Int J Biochem Cell Biol; 2018 May; 98():65-74. PubMed ID: 29535070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer.
    Luo H; Shan J; Zhang H; Song G; Li Q; Xu CX
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):960-970. PubMed ID: 35189321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors.
    Perrier A; Didelot A; Laurent-Puig P; Blons H; Garinet S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
    Rondelet G; Wouters J
    Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging epigenetics to enhance the efficacy of immunotherapy.
    Licht JD; Bennett RL
    Clin Epigenetics; 2021 May; 13(1):115. PubMed ID: 34001289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment.
    Gjerstorff MF; Burns J; Ditzel HJ
    Expert Opin Biol Ther; 2010 Jul; 10(7):1061-75. PubMed ID: 20420535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy.
    Zahnow CA; Topper M; Stone M; Murray-Stewart T; Li H; Baylin SB; Casero RA
    Adv Cancer Res; 2016; 130():55-111. PubMed ID: 27037751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.